Brain Disease Modalities and Software Market Exclusive Report with Detailed Study Analysis

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Disease Modalities And Software Market Size, Share & Trends Analysis Report By Product (Brain Imaging Modalities and Brain Analysis Software), By Type of Patients (Adults, Pediatrics and Infants), Region, Market Outlook And Industry Analysis 2034"

According to the latest research by InsightAce Analytic, the Global Brain Disease Modalities And Software Market Size is valued at 14.61 Billion in 2024 and is predicted to reach 24.53 Billion by the year 2034 at a 5.4% CAGR during the forecast period for 2025-2034.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1945

Brain disease modalities contain conventional imaging techniques like MRI, CT scans, PET, and combined functionalities of PET with MRI or CT. Computerized Tomography (CT) scan gives multi-angular cross-sectional X-ray images using tomography and digital geometry, while Magnetic Resonance Imaging (MRI) offers detailed images with the help of radio waves and magnetic fields. These imaging techniques are used to diagnose and monitor neural activity, cerebral oxygen capacity, strokes, tumours, blood pressure, traumatic cranial injury, and other critical functions.

Brain imaging software offers a significant addition to the scanned images obtained through these modalities for quantitative analysis. It provides detailed analysis with statistical data, which supports the diagnosis. Quantitative insights into the structure, biomarkers & other delicate abnormalities in the brain are helpful in assisting in a more precise diagnosis of neurological disorders.

Developing improvements and the growing use of artificial intelligence is the major driving factor of the market. The increasing prevalence of neurological disorders and demands for safer and non-invasive imaging devices will also drive the forecast market. There was a regression in demand for neuroimaging services, which was balanced by the necessity for respiratory imaging techniques and tests for COVID-19 treatment. In contrast, the usage of helium gas in imaging devices is affected due to shortage. The direct impact is on the performance and functioning of the device. The economic imbalance also retrieves the growing market as the investment for these devices, and the cost for the testing is high enough that the patient goes for the alternate modalities.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1945

North America and Europe are reported as the most significant shareholder of the brain diseases modalities and software market in 2022, while the Asia-Pacific region is expecting to grow at a higher CAGR due to the applications, technology, and end-use.

Competitive Landscape
Some of The Key Players in The Brain disease modalities and software Market:
• Quantib
• Brainomix
• Qure.AI
• General Electric Company
• Imaging Biometrics, LLC
• United Imaging Healthcare Co. Ltd.
• Siemens
• Healthineers AG
• Koninklijke Philips N.V.
• Canon Inc.
• Vuno Co. Ltd.
• Aspect Imaging
• IXICO
• QMENTA
• Cortechs.ai
• A.I. Analysis Inc.
• Fujifilm Holdings Corporation
• Other Prominent Players.

Key developments
• In Mar 2023, Brainomix declared that the FDA had approved its Brainomix 360 e-ASPECTS tool for stroke, allowing the Oxford-based business to introduce its cutting-edge stroke AI imaging technology to US stroke facilities.
• In Jan 2022, Quantib introduced a substantial upgrade to its AI-powered solution for brain atrophy and white matter hyperintensity progression called Quantib® ND 2.0. This upgrade was made possible by the company's commitment to continuous research and development. The solution has been given authorization by the FDA for use in clinical settings in the United States.
• In Nov 2021, Siemens Healthineers Launches World's First CT Scanner 'NAEOTOM Alpha' With Photon-Counting Technology. The photon-counting technology enables drastic improvements in radiation dose by up to 45 percent rise in reduction and resolution for ultra-high resolution (UHR) scans compared with traditional CT detectors.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customization/1945

Market Segments
Global Brain disease modalities and software Market segmented by Products, 2025-2034 (Value US$ Mn)
• Brain analysis software
 PET Devices
 CT Devices
 MRI Devices
 PET-CT
 PET-MRI
• Brain imaging modalities
Global Brain disease modalities and software Market segmented by Type of Patients, 2025-2034 (Value US$ Mn)
• Adults
• Pediatrics
• Infants
Global Brain disease modalities and software Market segmented by End-User, 2025-2034 (Value US$ Mn)

• Hospitals and clinics
• Ambulatory surgery centers
• Diagnostic imaging centers
Global Brain disease modalities and software Market segmented by Region, 2025-2034 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Get More Information @
https://www.insightaceanalytic.com/report/brain-disease-modalities-and-software-market/1945

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.